Barclays analyst Andrew Mok lowered the firm’s price target on Molina Healthcare (MOH) to $133 from $164 and keeps an Underweight rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Subpoenas issued to eight health insurers by House panel, Axios reports
- Molina Healthcare price target lowered to $145 from $170 at UBS
- Molina Healthcare price target lowered to $144 from $180 at Cantor Fitzgerald
- Molina Healthcare price target lowered to $144 from $175 at TD Cowen
- Molina Healthcare Earnings Call: Growth Wins vs. Strain
